+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prosthetic Heart Valve Market - Forecasts from 2025 to 2030

  • PDF Icon

    Report

  • 149 Pages
  • February 2025
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 6061772
The prosthetic heart valve market will grow to US$14.44 billion in 2030 from US$8.76 billion in 2025 at CAGR of 10.52% during this period.
  • The increasing prevalence of valvular heart diseases is driving the adoption of heart valves, thereby fueling market growth. Additionally, advancements in medical technology and treatments have heightened patient awareness about diagnosis, treatment options, and alternatives, further boosting market prospects. Supportive government regulations and improvements in healthcare infrastructure are also expected to contribute to market expansion during the forecast period.
  • North America holds a significant share of the market, driven by high rates of cardiovascular diseases, particularly in the U.S., where heart disease accounts for 1 in every 4 deaths. Meanwhile, the Asia Pacific region is poised for robust growth, supported by rising health awareness and increased healthcare investments.
  • The global Prosthetic Heart Valve Market report provides a detailed analysis of the industry landscape, offering strategic and executive-level insights supported by data-driven forecasts and comprehensive analysis. Regularly updated, the report equips decision-makers with actionable intelligence on current market trends, emerging opportunities, and competitive dynamics. It evaluates demand across various segments, including product types such as Mechanical Heart Valves and Tissue Heart Valves, and key end-user categories like Hospitals and Clinics, Research Laboratories, and Others. The report also explores procedure types, such as Surgical Valve Replacement and Transcatheter Valve Replacements, highlighting technological advancements in these areas. Additionally, it assesses critical government policies, regulatory frameworks, and macroeconomic factors, providing a holistic perspective of the market ecosystem.
Some of the major players covered in this report include Boston Scientific Corporation, Edwards Lifesciences Corporation, Abbott, Medtronic, JenaValve Technology Inc., Corcym S.r.l. (LivaNova PLC), CryoLife Inc, Meril Life Sciences Pvt. Ltd., Lepu Medical Technology Co., Ltd, TTK Healthcare Limited, Symetis SA among others.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What can businesses use this report for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence.

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Prosthetic Heart Valve Market Segmentations:

Prosthetic Heart Valve Market Segmentation by type:

The market is analyzed by type into the following:
  • Mechanical Heart Valve
  • Tissue Heart Valve

Prosthetic Heart Valve Market Segmentation by end-user:

The report analyzes the market by end-user as below:
  • Hospitals and Clinics
  • Research Laboratories
  • Others

Prosthetic Heart Valve Market Segmentation by procedure type:

The market is analyzed by product type into the following:
  • Surgical Valve Replacement
  • Transcatheter Valve Replacements

Prosthetic Heart Valve Market Segmentation by regions:

The study also analyzed the Prosthetic Heart Valve Market into the following regions, with country-level forecasts and analysis as below:
  • North America (US, Canada, and Mexico)
  • South America (Brazil, Argentina, and Others)
  • Europe (Germany, UK, France, Spain and Others
  • Middle East and Africa (Saudi Arabia, UAE and Others)
  • Asia Pacific (China, Japan, India, South Korea, Thailand, Indonesia, and Others)

Table of Contents

1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. PROSTHETIC HEART VALVE MARKET BY TYPE
5.1. Introduction
5.2. Mechanical Heart Valve
5.3. Tissue Heart Valve
6. PROSTHETIC HEART VALVE MARKET BY END-USER
6.1. Introduction
6.2. Hospitals and Clinics
6.3. Research Laboratories
6.4. Others
7. PROSTHETIC HEART VALVE MARKET BY PROCEDURE TYPE
7.1. Introduction
7.2. Surgical Valve Replacement
7.3. Transcatheter Valve Replacement
8. PROSTHETIC HEART VALVE MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Boston Scientific Corporation
10.2. Edwards Lifesciences Corporation
10.3. Abbott
10.4. Medtronic
10.5. JenaValve Technology Inc.
10.6. Corcym S.r.l. (LivaNova PLC)
10.7. CryoLife Inc
10.8. Meril Life Sciences Pvt. Ltd.
10.9. Lepu Medical Technology Co., Ltd
10.10. TTK Healthcare Limited
10.11. Symetis SA
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations

Companies Mentioned

  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Abbott
  • Medtronic
  • JenaValve Technology Inc.
  • Corcym S.r.l. (LivaNova PLC)
  • CryoLife Inc
  • Meril Life Sciences Pvt. Ltd.
  • Lepu Medical Technology Co., Ltd
  • TTK Healthcare Limited
  • Symetis SA

Methodology

Loading
LOADING...

Table Information